Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium

Cell Proliferation

Volumn 43, Issue 1, 2010, Pages 41-48

  Kimura, H ^a,b,c   Zhang, L ^a   Zhao, M ^a   Hayashi, K ^c   Tsuchiya, H ^c   Tomita, K ^c   Bouvet, M ^b   Wessels, J ^d   Hoffman, R M ^a,b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

A1 R; ANTINEOPLASTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; PARALYSIS; SALMONELLA TYPHIMURIUM; SPINAL CORD CANCER; SURVIVAL;

ANIMALS; BIOLOGICAL THERAPY; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GLIOMA; HUMANS; INJECTIONS, SPINAL; MICE; MICE, NUDE; NUCLEAR PROTEINS; ORGANISMS, GENETICALLY MODIFIED; PARALYSIS; SALMONELLA TYPHIMURIUM; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; SALMONELLA TYPHIMURIUM;

EID: 73349121297     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00652.x     Document Type: Article

References (45)

1. Russel DS, Rubinstein LJ (1989) Pathology of Tumors of the Nervous System. Baltimore : Williams & Wilkins, 83 p.
2. Bowers DC, Weprin BE (2003) Intramedullary spinal cord tumors. Curr. Treat. Options Neurol. 5, 207 212.
3. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ (2000) Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J. Neurosurg. 93 (2 Suppl. 183 193.
4. Sandler HM, Papadopoulos SM, Thornton AF Jr., Ross DA (1992) Spinal cord astrocytomas: results of therapy. Neurosurgery 30, 490 493.
5. Townsend N, Handler M, Fleitz J, Foreman N (2004) Intramedullary spinal cord astrocytomas in children. Pediatr. Blood Cancer 43, 629 632.
6. McLaughlin MP, Buatti JM, Marcus RB Jr., Maria BL, Mickle PJ, Kedar A (1998) Outcome after radiotherapy of primary spinal cord glial tumors. Radiat. Oncol. Investig. 6, 276 280.
7. Shirato H, Kamada T, Hida K, Koyanagi I, Iwasaki Y, Miyasaka K et al. (1995) The role of radiotherapy in the management of spinal cord glioma. Int. J. Radiat. Oncol. Biol. Phys. 33, 323 328.
8. Coley WB (1906) Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and Bacillus prodigiosus. Am. J. Med. Sci. 131, 375 430.
9. Malmgren RA, Flanigan CC (1955) Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res. 15, 473 478.
10. Gericke D, Engelbart K (1964) Oncolysis by clostridia. II Experiments on a tumor spectrum with a variety of clostridia in combination with heavy metal. Cancer Res. 24, 217 221.
11. Moese JR, Moese G (1964) Oncolysis by clostridia. I. Activity of clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res. 24, 212 216.
12. Thiele EH, Arison RN, Boxer GE (1964) Oncolysis by clostridia. III Effects of clostridia and chemotherapeutic agents on rodent tumors. Cancer Res. 24, 222 233.
13. Kohwi Y, Imai K, Tamura Z, Hashimoto Y (1978) Antitumor effect of Bifidobacterium infantis in mice. Gann 69, 613 618.
14. Kimura NT, Taniguchi S, Aoki K, Baba T (1980) Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res. 40, 2061 2068.
15. Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP et al. (1996) Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther. 3, 173 178.
16. Lemmon MJ, van Zijl P, Fox ME, Mauchline ML, Giaccia AJ, Minton NP et al. (1997) Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther. 4, 791 796.
17. Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408 1416.
18. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M et al. (1999) Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat. Biotechnol. 17, 37 41.
19. Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J et al. (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J. Infect. Dis. 181, 1996 2002.
20. Sznol M, Lin SL, Bermudes D, Zheng LM, King I (2000) Use of preferentially replicating bacteria for the treatment of cancer. J. Clin. Invest. 105, 1027 1030.
21. Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi S (2000) Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 7, 269 274.
22. Yazawa K, Fujimori M, Nakamura T, Sasaki T, Amano J, Kano Y et al. (2001) Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res. Treat. 66, 165 170. (Pubitemid 32521423)
23. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc. Natl. Acad. Sci. USA 98, 15155 15160.
24. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238 239.
25. Pawelek JM, Low KB, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537 4544.
26. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ et al. (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142 152.
27. Mengesha A, Dubois L, Lambin P, Landuyt W, Chiu RK, Wouters BG et al. (2006) Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella. Cancer Biol. Ther. 5, 1120 1128.
28. Yu YA, Timiryasova T, Zhang Q, Beltz R, Szalay AA (2003) Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals. Anal. Bioanal. Chem. 377, 964 972.
29. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I et al. (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat. Biotechnol. 22, 313 320.
30. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S et al. (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 102, 755 760. (Pubitemid 40282738)
31. Zhao M, Yang M, Ma H, Li X, Tan X, Li S et al. (2006) Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res. 66, 7647 7652.
32. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM (2007) Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc. Natl. Acad. Sci. USA 104, 10170 10174.
33. Hoffman RM, Yang M (2006) Subcellular imaging in the live mouse. Nat. Protoc. 1, 775 782.
34. Hoffman RM, Yang M (2006) Color-coded fluorescence imaging of tumor-host interactions. Nat. Protoc. 1, 928 935.
35. Hoffman RM, Yang M (2006) Whole-body imaging with fluorescent proteins. Nat. Protoc. 1, 1429 1438.
36. Hoffman RM, Zhao M (2006) Whole-body imaging of bacterial infection and antibiotic response. Nat. Protoc. 1, 2988 2994.
37. Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K et al. (2009) Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J. Cell. Biochem. 106, 992 998.
38. Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA et al. (1996) MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 13, 343 359.
39. Doireau V, Grill J, Zerah M, Lellouch-Tubiana A, Couanet D, Chastagner P et al. (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP). Br. J. Cancer 81, 835 840.
40. O'Sullivan C, Jenkin RD, Doherty MA, Hoffman HJ, Greenberg ML (1994) Spinal cord tumors in children: long-term results of combined surgical and radiation treatment. J. Neurosurg. 81, 507 512.
41. Parsa AT, Lee J, Parney IF, Weinstein P, McCormick PC, Ames C (2004) Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J. Neurooncol. 69, 291 318.
42. Cheong I, Huang X, Bettegowda C, Diaz LA Jr., Kinzler KW, Zhou S et al. (2006) A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science 314, 1308 1311.
43. Juliano R (2007) Bugging tumors to put drugs on target. N. Engl. J. Med. 356, 954 955.
44. Stapleton S, Blaney S (2006) New agents for intrathecal administration. Cancer Invest. 24, 528 534.
45. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N et al. (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N. Engl. J. Med. 352, 978 986.